CoTherix's Series B - II Round

CoTherix raised a round of funding on August 22, 2003.

CoTherix is dedicated to the development and commercialization of improved therapies for inflammatory lung diseases. The company was formed in 2000 with the initial focus of commercializing a decade o…

Articles about CoTherix's Series B - II Round: